Asymmetry Ventures | Activity | F4

Team Portfolio Raise Essays

F4/Asymmetry Ventures/Activity

Asymmetry Ventures Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

News

Asymmetry Ventures was selected by Business Insider to its 'Seed 100' rankings of the world's top early-stage investors.

Asymmetry Ventures

Asymmetry VenturesAsymmetry Ventures

Added recently

Milestone

Portfolio company TYBR Health closed a $30M Series A led by Vensana Capital and Mutual Capital Partners to expand access to its FDA-cleared B3 GEL System.

TYBR Health

TYBR Health Asymmetry Ventures

prnewswire.comJUL 21, 2026

JUL 21, 2026

3 investments· OCT 2025 – APR 2026Show all

Investment

Asymmetry Ventures participated in a $3M Seed round for Patent Watch in April 2026.

Patent Watch

Patent Watch Asymmetry Ventures

theventurecodex.comAPR 2026

APR 2026

Investment

Invested in Enlightra's $15M Series A for AI/quantum optical interconnects and energy-efficient data center lasers.

Enlightra

Enlightra Asymmetry Ventures

nordic9.comDEC 18, 2025

thequantuminsider.com

thequantuminsider.com

DEC 18, 2025

Investment

Asymmetry Ventures participated in a $15M Seed round for TransCrypts alongside Pantera Capital in October 2025.

TransCrypts

TransCrypts Asymmetry Ventures

theventurecodex.comOCT 2025

OCT 2025

Milestone

Portfolio company TYBR Health received FDA 510(k) clearance for its B3 GEL System, a bioresorbable gel that protects healing tissue during surgical recovery.

TYBR Health

TYBR Health Asymmetry Ventures

biospace.comJUN 9, 2025

JUN 9, 2025

Investment

Co-invested in PERSIST.AI's $12M Series A for AI-driven robotic pharmaceutical formulation development.

PERSIST.AI

PERSIST.AI Asymmetry Ventures

prnewswire.comMAY 19, 2025

MAY 19, 2025

Investment

Participated in Coreshell's $24M Series A2 round for domestically-sourced silicon battery anodes for EVs.

Coreshell

Coreshell Asymmetry Ventures

techcrunch.comMAR 18, 2025

MAR 18, 2025

Exit

Portfolio company Atomic Alchemy was acquired by Oklo for $25M to expand radioisotope production and supply chain.

Atomic Alchemy

Atomic Alchemy Asymmetry Ventures

businesswire.comMAR 2025

MAR 2025